Samir Sejpal, MD
Radiation Oncology · Orlando, FLNPI 1447416508
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for radiation oncology clinicians in FL, where the typical reported total is $724.
Across 36 payments — averaging $25.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Varian Medical Systems, Inc.$104
- Pfizer$101
- AstraZeneca$88
- Medtronic$78
- Stemline Therapeutics Inc.$69
- Incyte Corporation$55
- plus $408 from 16 others
What the payments were for
- Food & beverage$903100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Varian Medical Systems, Inc. | 1 | $104 |
| Pfizer | 4 | $101 |
| AstraZeneca | 4 | $88 |
| Medtronic | 1 | $78 |
| Stemline Therapeutics Inc. | 4 | $69 |
| Incyte Corporation | 3 | $55 |
| Adaptive Biotechnologies Corporation | 2 | $46 |
| Johnson & Johnson | 2 | $43 |
| Brainlab, Inc. | 1 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Sobi, Inc | 1 | $27 |
| Tactile Systems Technology Inc | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| GSK | 1 | $24 |
| EMD Serono, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Mirati Therapeutics, Inc. | 1 | $22 |
| EUSA Pharma (US) LLC | 1 | $17 |
| Bayer | 1 | $17 |
| Amgen | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Novocure Inc. | 1 | $13 |
How this compares
$903 in reported general payments places this provider in the 50th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 34 | $359 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Orlando
- Shravan KandulaOrlando$444K
- Ravi ShridharOrlando$192K
- Akash NandaOrlando$165K
- Imran MohiuddinOrlando$93K
- Charles HodgeOrlando$34K
- Bridget KoontzOrlando$26K
- Justin RineerOrlando$11K
- Matthew BiagioliOrlando$10K
- Shiv DesaiOrlando$8K
- Nina JohnsonOrlando$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.